Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers

CompletedOBSERVATIONAL
Enrollment

1,546

Participants

Timeline

Start Date

June 7, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
COVIDCorona Virus Infection
Interventions
BIOLOGICAL

Specific anti-SARS-CoV-2 antibodies

"A serum sample needs to be collected from each participant upon recruitment into the investigation All samples will be tested by the rapid test (Artron, Artron Laboratories, Burnaby, Canada), IgM / IgG which is an antibody capture Immunochromatografac assay for simultaneous detection of IgM and IgG in serum or plasma for COVID -19 in samples.~All samples will be tested for total Immunoglobulins and IgG in samples for COVID-19 virus by Ortho clinical diagnostics chemiluminescent technique (Ortho, Raritan, USA)."

Trial Locations (2)

32

ECRRM, Cairo

Unknown

Faculty of Medicine, Cairo University, Cairo

All Listed Sponsors
collaborator

Cairo University

OTHER

collaborator

National Research Centre, Egypt

OTHER

collaborator

Academy of Scientific Research and Technology, Egypt

OTHER

lead

Egyptian Center for Research and Regenerative Medicine

OTHER_GOV

NCT04424017 - Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers | Biotech Hunter | Biotech Hunter